These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3398646)
1. Adaptive changes in the effects of angiotensin II on the convulsive-seizure threshold in cases of altered sensitivity of dopamine receptors. Georgiev V; Petkova B; Kambourova T Methods Find Exp Clin Pharmacol; 1988 May; 10(5):295-9. PubMed ID: 3398646 [TBL] [Abstract][Full Text] [Related]
2. Involvement of transmitter mechanisms in the behavioural effects of angiotensin II. Georgiev V Pol J Pharmacol Pharm; 1990; 42(6):553-62. PubMed ID: 1983291 [TBL] [Abstract][Full Text] [Related]
3. Interactions of angiotensin II with piracetam in exploratory behavior and convulsive-seizure threshold. Georgiev V; Petkova B; Kambourova T; Opitz M Acta Physiol Pharmacol Bulg; 1989; 15(1):70-5. PubMed ID: 2773651 [TBL] [Abstract][Full Text] [Related]
4. Brain dopamine and seizure susceptibility in mice. Kleinrok Z; Czuczwar S; Wójcik A; Przegaliński E Pol J Pharmacol Pharm; 1978; 30(4):513-9. PubMed ID: 740553 [TBL] [Abstract][Full Text] [Related]
5. Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: possible involvement of noradrenergic mechanism. Tchekalarova J; Georgiev V Neuropeptides; 2006 Oct; 40(5):339-48. PubMed ID: 17045647 [TBL] [Abstract][Full Text] [Related]
6. Dopaminergic influence on the effects of angiotensin II in behavioural reactions. Georgiev V; György L; Yonkov D; Getova D; Markovska V; Petkova B Physiol Bohemoslov; 1985; 34 Suppl():45-8. PubMed ID: 3014581 [TBL] [Abstract][Full Text] [Related]
7. Interactions of angiotensin II and GABA-ergic agents at the threshold of convulsive reactions. Georgiev VP; Petkova BP; Petkov VD; Kambourova TS Acta Physiol Pharmacol Bulg; 1986; 12(2):14-20. PubMed ID: 3020873 [TBL] [Abstract][Full Text] [Related]
8. Are the central dopaminergic synapses related to the convulsive-seizure threshold?--Effects of central dopaminergic drugs on the picrotoxin convulsive-seizure threshold. Interaction with diazepam, meta-tolylcarbamide and theophylline. Markovska VL; Georgiev VP Acta Physiol Pharmacol Bulg; 1976; 2(4):59-65. PubMed ID: 1029380 [No Abstract] [Full Text] [Related]
9. Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism. Akula KK; Dhir A; Kulkarni SK Epilepsy Res; 2008 Jan; 78(1):60-70. PubMed ID: 18054463 [TBL] [Abstract][Full Text] [Related]
10. Some central effects of angiotensin II. Interactions with dopaminergic transmission. Georgiev V; György L; Getova D; Markovska V Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944 [TBL] [Abstract][Full Text] [Related]
11. Effects of [arginine8, glycine-OH9]-vasopressin on pentylenetetrazol seizures in mice. Interaction with adrenaline. Lambadjieva ND; Georgiev VP; Kambourova TS Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):161-6. PubMed ID: 9203163 [TBL] [Abstract][Full Text] [Related]
12. Comparative studies on the central effects of the angiotensin II analogue (Sar1 azaVal3 Ile8) AT II. Georgiev VP; Klusha VE; Getova DP; Petkov VD; Svirskis SV; Mutsenietse RK; Kambourova TS; Oppitz MZh; Ancans JE Acta Physiol Pharmacol Bulg; 1988; 14(1):22-9. PubMed ID: 3407412 [TBL] [Abstract][Full Text] [Related]
13. On some relationships between dopaminergic and serotoninergic mechanisms in pentylenetetrazol convulsions in albino mice. Lazarova M; Roussinov K Acta Physiol Pharmacol Bulg; 1979; 5(3):67-74. PubMed ID: 317212 [TBL] [Abstract][Full Text] [Related]
14. Behavioural effects of angiotensin II in the mouse following MPTP administration. Georgiev V; Kambourova T Gen Pharmacol; 1991; 22(4):625-30. PubMed ID: 1657686 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of dopamine D1 and D2 receptors in the basal ganglia of PTZ kindling model of epilepsy: effects of angiotensin IV. Tchekalarova J; Sotiriou E; Angelatou F Brain Res; 2004 Oct; 1024(1-2):159-66. PubMed ID: 15451378 [TBL] [Abstract][Full Text] [Related]
16. Central effects of angiotensin II, its fragment and analogues. Georgiev VP; Klousha VE; Petkov VD; Markovska VL; Svirskis SV; Mountsinietse RK; Anouans ZE Acta Physiol Pharmacol Bulg; 1984; 10(4):36-43. PubMed ID: 6085530 [TBL] [Abstract][Full Text] [Related]
17. Effect of systemic administration of adenosine on brain adenosine levels in pentylenetetrazol-induced seizure threshold in mice. Akula KK; Dhir A; Bishnoi M; Kulkarni SK Neurosci Lett; 2007 Sep; 425(1):39-42. PubMed ID: 17720312 [TBL] [Abstract][Full Text] [Related]
18. Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice. Riffee WH; Wilcox RE; Goldman CP; Smith RV Psychopharmacology (Berl); 1981; 75(4):391-5. PubMed ID: 6803286 [TBL] [Abstract][Full Text] [Related]
19. Seizure susceptibility alteration following reversible cholestasis in mice: Modulation by opioids and nitric oxide. Gholipour T; Riazi K; Noorian AR; Jannati A; Honar H; Doratotaj B; Nik HH; Shariftabrizi A; Dehpour AR Eur J Pharmacol; 2008 Feb; 580(3):322-8. PubMed ID: 18164287 [TBL] [Abstract][Full Text] [Related]
20. On certain effects of dopaminergic agents in pentylenetetrazol convulsions. Lazarova MB; Roussinov KS Acta Physiol Pharmacol Bulg; 1978; 4(3):50-5. PubMed ID: 751452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]